Notably, altering T-cell ferroptosis-related metabolic targets, such as promoting ferroptosis in Treg cells or inhibiting ferroptosis in CD8+ T cells, has been shown to improve cancer prognosis. The gene discussed is CD8A; the disease is cancer.